Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
281.10Prev. Close
283.50Volume
4,97,878Total traded value
14.63 CrUpper Circuit
323.25Lower Circuit
264.55Fundamentals
| Market Cap | ₹4,611Cr |
| ROE | -0.34% |
| P/E Ratio(TTM) | 44.23 |
| EPS(TTM) | 6.65 |
| P/B Ratio | 0.79 |
| Dividend Yield | 0.00% |
| Industry P/E | 34.67 |
| Book Value | 371.95 |
| Debt to Equity | 0.41 |
| Face Value | 2 |
Understand Fundamentals
Financials
About Dishman Carbogen Amcis
Dishman Carbogen Amcis, also known as 'imdcal', is a leading Contract Research and Manufacturing Services (CRAMS) provider for the global pharmaceutical and bio-technology industries. The company aims to be the partner of choice for customers to develop and manufacture complex and highly potent active ingredients, breaking new ground with innovation. Demonstrating resilient financial performance, its Revenue from Operations increased from ₹2,412.9 crores in FY23 to ₹2,615.8 crores, registering a growth of 8.4% YoY.;
| Parent Organisation | Dishman Carbogen Amcis |
| Managing Director | Mr. Arpit Vyas |
| NSE Symbol | DCAL |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Top Mutual Funds Invested(1)
| FUND NAME | AUM(%) |
|---|---|
| HSBC Flexi Cap Fund Direct Growth | 0.81% |
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 105.21 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 34.98 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.27 | ||
| Wockhardt | NA (0.00%) | -154.77 |